Annual Accounts Receivable
$31.99 M
+$3.92 M+13.96%
December 31, 2024
Summary
- As of March 13, 2025, ENFN annual accounts receivable is $31.99 million, with the most recent change of +$3.92 million (+13.96%) on December 31, 2024.
- During the last 3 years, ENFN annual accounts receivable has risen by +$13.77 million (+75.54%).
- ENFN annual accounts receivable is now at all-time high.
Performance
ENFN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$31.99 M
-$185.00 K-0.58%
December 31, 2024
Summary
- As of March 13, 2025, ENFN quarterly accounts receivable is $31.99 million, with the most recent change of -$185.00 thousand (-0.58%) on December 31, 2024.
- Over the past year, ENFN quarterly accounts receivable has increased by +$3.92 million (+13.96%).
- ENFN quarterly accounts receivable is now -5.00% below its all-time high of $33.67 million, reached on June 30, 2024.
Performance
ENFN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ENFN Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.0% | +14.0% |
3 y3 years | +75.5% | +28.7% |
5 y5 years | +256.4% | +28.7% |
ENFN Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +75.5% | -5.0% | +75.5% |
5 y | 5-year | at high | +256.4% | -5.0% | +162.6% |
alltime | all time | at high | +256.4% | -5.0% | +162.6% |
Enfusion Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $31.99 M(+14.0%) | $31.99 M(-0.6%) |
Sep 2024 | - | $32.17 M(-4.5%) |
Jun 2024 | - | $33.67 M(+8.9%) |
Mar 2024 | - | $30.93 M(+10.2%) |
Dec 2023 | $28.07 M(+8.6%) | $28.07 M(+12.9%) |
Sep 2023 | - | $24.86 M(-1.3%) |
Jun 2023 | - | $25.17 M(+3.3%) |
Mar 2023 | - | $24.36 M(-5.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $25.86 M(+41.9%) | $25.86 M(-10.8%) |
Sep 2022 | - | $28.99 M(+0.8%) |
Jun 2022 | - | $28.77 M(+22.9%) |
Mar 2022 | - | $23.41 M(+28.5%) |
Dec 2021 | $18.22 M(+49.6%) | $18.22 M(-4.1%) |
Sep 2021 | - | $19.00 M(+22.8%) |
Jun 2021 | - | $15.47 M(+27.0%) |
Dec 2020 | $12.18 M(+35.7%) | $12.18 M |
Dec 2019 | $8.97 M | - |
FAQ
- What is Enfusion annual accounts receivable?
- What is the all time high annual accounts receivable for Enfusion?
- What is Enfusion annual accounts receivable year-on-year change?
- What is Enfusion quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Enfusion?
- What is Enfusion quarterly accounts receivable year-on-year change?
What is Enfusion annual accounts receivable?
The current annual accounts receivable of ENFN is $31.99 M
What is the all time high annual accounts receivable for Enfusion?
Enfusion all-time high annual accounts receivable is $31.99 M
What is Enfusion annual accounts receivable year-on-year change?
Over the past year, ENFN annual accounts receivable has changed by +$3.92 M (+13.96%)
What is Enfusion quarterly accounts receivable?
The current quarterly accounts receivable of ENFN is $31.99 M
What is the all time high quarterly accounts receivable for Enfusion?
Enfusion all-time high quarterly accounts receivable is $33.67 M
What is Enfusion quarterly accounts receivable year-on-year change?
Over the past year, ENFN quarterly accounts receivable has changed by +$3.92 M (+13.96%)